Printer Friendly

ADVANCED TECHNOLOGY LABORATORIES NAMES GILLIS SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

 ADVANCED TECHNOLOGY LABORATORIES NAMES GILLIS
 SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
 BOTHELL, Wash., Sept. 2 /PRNewswire/ -- Dennis C. Fill, chairman and chief executive officer of Advanced Technology Laboratories Inc. (NASDAQ-NMS: ATLI) (ATL), announced today the appointment of Harvey N. Gillis as senior vice president, finance and administration, and chief financial officer of the company.
 Gillis's career of over 20 years spans almost all aspects of managing corporate financial planning and controllership, tax, pension management and investor relations. Gillis, 46, has served in various senior management positions in companies ranging from international banking institutions to privately held companies as well as public companies in the early stages of product development and rapid growth.
 "We are most pleased to welcome Harvey to ATL and believe that his diverse and strong financial experience will make important contributions to the company's future," Fill said.
 Most recently, Gillis held the position of senior vice president, finance and administration, and chief financial officer for Neopath Inc., a biomedical company located in Bellevue, Wash. For the six prior years, he served as chief operating officer for Samuel Stroum Enterprises of Seattle. He also served in senior financial management positions with Seafirst Corp. of Seattle, with Bank of America and Mediagenic of Mountain View, Calif.
 Gillis received both his M.S. degree in operations research and his M.B.A. degree in finance and systems analysis from Stanford University. He received his B.S. in chemical engineering with a minor in economics from Carnegie Mellon University.
 Gillis also serves on the board of directors for Digital Systems International and Edmark Corp., both located in Redmond, Wash.
 ATL, with headquarters in Bothell, Wash., is a worldwide leader in the development, manufacture and distribution of diagnostic ultrasound systems. ATL stock is traded on the NASDAQ National Market System under the symbol ATLI.
 -0- 9/2/92
 /CONTACT: Anne Marie Bugge of Advanced Technology Laboratories, 206-487-7081/
 (ATLI) CO: Advanced Technology Laboratories Inc. ST: Washington IN: MTC SU: PER


TM-SC -- SE003 -- 5893 09/02/92 12:00 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 2, 1992
Words:337
Previous Article:JM FAMILY/SOUTHEAST TOYOTA HURRICANE RELIEF FUND ESTABLISHED THROUGH BROWARD COMMUNITY FOUNDATION
Next Article:JAPANESE VERSION OF PENPOINT GAINS BROAD INDUSTRY SUPPORT FROM OEMS, ISVS AND SOFTBANK TECHNOLOGIES
Topics:


Related Articles
ADVANCED TECHNOLOGY LABORATORIES ANNOUNCES PROGRAM FOR ODDLOT SHAREHOLDERS
ATL SIGNS LETTER OF INTENT TO PURCHASE ELDEC PROPERTY
INNERDYNE INC. ANNOUNCES APPOINTMENT OF JAMES T. McKINLEY AS SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
ATL ANNOUNCES ORGANIZATIONAL CHANGES
BioGenex Laboratories Names Richard Wieland Senior Vice President and Chief Financial Officer
Gillis Named ComEd Vice President and Treasurer
Corixa Corporation Announces Senior Management Promotions.
Unicom Hires New President of Competitive Operations; Announces Related Changes in Senior Management.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters